Two Decades of Triazine Dendrimers.
MRI
RNA delivery
VOC
atrazine
biological activity
composite
dendrimer
drug delivery
gene delivery
materials
membrane
nanoparticle
paclitaxel
physical organic chemistry
separation
synthesis
theranostic
triazine
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
06 Aug 2021
06 Aug 2021
Historique:
received:
29
03
2021
revised:
13
07
2021
accepted:
16
07
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
For two decades, methods for the synthesis and characterization of dendrimers based on [1,3,5]-triazine have been advanced by the group. Motivated by the desire to generate structural complexity on the periphery, initial efforts focused on convergent syntheses, which yielded pure materials to generation three. To obtain larger generations of dendrimers, divergent strategies were pursued using iterative reactions of monomers, sequential additions of triazine and diamines, and ultimately, macromonomers. Strategies for the incorporation of bioactive molecules using non-covalent and covalent strategies have been explored. These bioactive materials included small molecule drugs, peptides, and genetic material. In some cases, these constructs were examined in both in vitro and in vivo models with a focus on targeting prostate tumor subtypes with paclitaxel conjugates. In the materials realm, the use of triazine dendrimers anchored on solid surfaces including smectite clay, silica, mesoporous alumina, polystyrene, and others was explored for the separation of volatile organics from gas streams or the sequestration of atrazine from solution. The combination of these organics with metal nanoparticles has been probed. The goal of this review is to summarize these efforts.
Identifiants
pubmed: 34443361
pii: molecules26164774
doi: 10.3390/molecules26164774
pmc: PMC8401192
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Robert A. Welch Foundation
ID : P-0008
Références
Nanomedicine. 2019 Apr;17:266-275
pubmed: 30794962
J Am Chem Soc. 2003 Apr 30;125(17):5086-94
pubmed: 12708859
Mol Pharm. 2004 Sep-Oct;1(5):390-3
pubmed: 16026011
Macromolecules. 2009 Apr 28;42(8):3152-3161
pubmed: 20725528
J Polym Sci A Polym Chem. 2006 Jun 1;44(11):3411-3433
pubmed: 19953202
Polym Int. 2007 Mar 2;56(4):489-496
pubmed: 19960104
Mol Pharm. 2012 Mar 5;9(3):404-12
pubmed: 22260328
J Org Chem. 2008 Mar 21;73(6):2357-66
pubmed: 18307354
J Org Chem. 2007 Dec 21;72(26):9866-74
pubmed: 18052073
Int J Pharm. 2004 Aug 20;281(1-2):129-32
pubmed: 15288350
Molecules. 2016 May 11;21(5):
pubmed: 27187331
J Am Chem Soc. 2013 Mar 27;135(12):4660-3
pubmed: 23398590
Bioconjug Chem. 2009 Nov;20(11):2154-61
pubmed: 19877601
Adv Drug Deliv Rev. 2012 Jun 15;64(9):826-35
pubmed: 22465784
Bioconjug Chem. 2012 Nov 21;23(11):2291-9
pubmed: 23035964
Nanoscale. 2017 Aug 3;9(30):10966
pubmed: 28731113
Tetrahedron Lett. 2010 Mar 31;51(13):1631-1634
pubmed: 23585699
Organic Synth. 2009 Jan 1;86:141-150
pubmed: 19784386
Tetrahedron Lett. 2008 Feb 11;49(17):1152-1154
pubmed: 19629195
Org Lett. 2006 May 25;8(11):2293-5
pubmed: 16706509
J Agric Food Chem. 2004 Feb 11;52(3):545-9
pubmed: 14759146
Organic Synth. 2009 Jan 1;86:151
pubmed: 20072717
Org Lett. 2013 Aug 2;15(15):3808-11
pubmed: 23869522
Biomed Opt Express. 2011 Apr 18;2(5):1243-57
pubmed: 21559135
Mol Pharm. 2010 Aug 2;7(4):993-1006
pubmed: 20481608
Mol Pharm. 2005 Jul-Aug;2(4):273-7
pubmed: 16053330
J Control Release. 2011 Jul 15;153(1):23-33
pubmed: 21342661
Biomacromolecules. 2010 Mar 8;11(3):721-30
pubmed: 20131771
Org Lett. 2010 Mar 19;12(6):1148-51
pubmed: 20170155
Angew Chem Int Ed Engl. 2004 Oct 4;43(39):5178-80
pubmed: 15317013
Macromolecules. 2009 Aug 12;42(17):6723-3732
pubmed: 20711424
Mol Pharm. 2010 Aug 2;7(4):969-83
pubmed: 20524664
Bioorg Med Chem. 2010 Aug 1;18(15):5749-53
pubmed: 20615715
Org Lett. 2003 Jun 26;5(13):2359-61
pubmed: 12816448
Biomolecules. 2019 Aug 28;9(9):
pubmed: 31466360
Macromolecules. 2008 Jun 24;41(12):4108-4114
pubmed: 19946610
Org Lett. 2008 Jan 17;10(2):201-4
pubmed: 18088131
Bioconjug Chem. 2003 Mar-Apr;14(2):488-93
pubmed: 12643761
Mol Pharm. 2013 Dec 2;10(12):4452-61
pubmed: 24134039
J Am Chem Soc. 2001 Sep 19;123(37):8914-22
pubmed: 11552798
New J Chem. 2007 Jul 1;31(7):1283-1290
pubmed: 20037678
New J Chem. 2009;33:1918-1925
pubmed: 19960102
J Am Chem Soc. 2012 Feb 1;134(4):1942-5
pubmed: 22239724
Bioconjug Chem. 2009 Sep;20(9):1799-806
pubmed: 19708683
Biomaterials. 2011 Nov;32(33):8702-11
pubmed: 21864902
Isr J Chem. 2009 Jan 1;49(1):23-30
pubmed: 19936277
Org Lett. 2003 Apr 17;5(8):1245-7
pubmed: 12688730
Molecules. 2016 Mar 10;21(3):335
pubmed: 26978338
Chem Commun (Camb). 2009 Oct 7;(37):5541-2
pubmed: 19753350
J Am Chem Soc. 2014 May 14;136(19):6850-3
pubmed: 24785836
Mol Pharm. 2008 Jul-Aug;5(4):540-7
pubmed: 18672950
Org Lett. 2000 Mar 23;2(6):843-845
pubmed: 10814438
Chemosphere. 2006 Jul;64(5):704-10
pubmed: 16403547
Molecules. 2016 Mar 29;21(4):428
pubmed: 27043508
Expert Opin Drug Discov. 2013 Sep;8(9):1057-69
pubmed: 23826946